Stiolto Respimat

Stiolto Respimat

Stiolto Respimat Recall

Get an alert when a recall is issued.

Questions & Answers

Side Effects & Adverse Reactions

Metaxalone may enhance the effects of alcohol and other CNS depressants.

Legal Issues

There is currently no legal information available for this drug.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Uses

Metaxalone is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomforts associated with acute, painful musculoskeletal conditions. The mode of action of this drug has not been clearly identified, but may be related to its sedative properties. Metaxalone does not directly relax tense skeletal muscles in man.

History

There is currently no drug history available for this drug.

Other Information

Metaxalone is available as an 800 mg, light pink to pink, capsule shaped, scored uncoated tablet.

Chemically, metaxalone is 5-[(3,5- dimethylphenoxy) methyl]-2-oxazolidinone. The empirical formula is C 12H 15NO 3, which corresponds to a molecular weight of 221.25. The structural formula is:

Structure

Metaxalone is a white to almost white, odorless crystalline powder freely soluble in chloroform, soluble in methanol and in 96% ethanol, but practically insoluble in ether or water.

Each tablet contains 800 mg metaxalone and the following inactive ingredients: calcium carbonate, FD&C Red #40, hypromellose, lactose monohydrate, microcrystalline cellulose, povidone, silicone dioxide, sodium starch glycolate and sodium stearyl fumarate.

Stiolto Respimat Manufacturers


  • Boehringer Ingelheim Pharmaceuticals Inc.
    Stiolto Respimat (Tiotropium Bromide And Olodaterol) Spray, Metered [Boehringer Ingelheim Pharmaceuticals Inc.]

Login To Your Free Account